MedPage Today on MSN6d
Broadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ART
SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
Neutralizing antibodies for treating hepatitis E in high-risk patients identified
Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with a weakened ...
Assessing the prevalence of neutralizing antibodies in individuals with Niemann-Pick disease
A new study in the journal Human Gene Therapy showed that more than half of individuals with Niemann-Pick disease, type C1 ...
Tech Explorist6d
Breakthrough antibody therapies offer hope for HIV treatment
Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...
Immune response may be harnessed to control HIV, primary trial results suggest
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
C&EN8d
Building a better COVID-19 vaccine
One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...
Gilead Presents New HIV Treatment And Cure Research Data
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
EurekAlert!8d
Prevalence of neutralizing antibodies to AAV2 and AAV9 in individuals with Niemann-Pick disease
A new study in the peer-reviewed journal Human Gene Therapy showed that more than half of individuals with Niemann-Pick ...